To study physiologic factors affecting the blood pressure (BP) response to nonpharmacologic maneuvers, fasting blood glucose, insulin, lipid and mineral levels, urinary mineral excretion, and the calcium regulating hormones parathyroid hormone ( 
M uch epidemiologic, experimental, and clinical data confirm the relevance of nutritional factors in determining blood pressure (BP) in the population as a whole, and among subjects with hypertension. Factors epidemiologically related to BP such as weight, caloric intake, 1 and the minerals sodium, potassium, calcium, and magnesium [2] [3] [4] also have been the focus of therapeutic intervention trials. These trials have shown that lowering dietary calorie, alcohol, or salt content, and providing increased amounts of calcium, potassium, or magnesium may each lower BP in at least some "sensitive" subjects. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] However, because specific intervention trials in the past have focused mainly on modifying these factors in isolation from other dietary components, the roles of these nutritional factors as they occur naturally in food, as well as of unidentified factors in the overall diet, are less well understood. Only recently have trials been published that investigate the impact of a comprehensive nutritional program designed to incorporate recommendations for optimal health as currently understood, [15] [16] [17] testing the combined efficacy of altered caloric, mineral, and other dietary components together as they occur in the diet. The recent development of one such food program has allowed us to compare its effects among normolipidemic and hyperlipidemic hypertensive and normotensive subjects. To investigate the potential physiologic mechanisms underlying the antihypertensive effects of diet, we have chosen to analyze the relationships of the BP, ionic, and metabolic consequences of these dietary interventions among unmedicated participants in the originally reported study population, 16 free of the concomitant influence of antihypertensive and antilipemic medications that, themselves, may influence both BP and these variables.
METHODS
Clinical Methods Unmedicated subjects with essential hypertension and/or hyperlipidemia were part of a larger multicenter, 10-week dietary intervention trial previously described. 16 Criteria for essential hypertension were, in the absence of signs or symptoms of secondary hypertension, basal BP Ͼ 140 -180/90 -105 mm Hg in the unmedicated state for at least 1 month before entering the study. Hyperlipidemia was defined as a total cholesterol level of 220 -300 mg% and/or a triglyceride level of 200 -1000 mg%. In the 4-week baseline period (week Ϫ4 to 0), subjects continued on their usual diets. A medical history and physical examination, two sets of 3-day food records, and weekly BP and weight measurements were obtained. After week Ϫ2, subjects were randomized to either: 1) a prepared nutritional program developed by the Campbell Center for Nutrition and Wellness (CCNW) to conform to the RDA standards specified by the National Academy of Sciences, American Diabetes Association, American Heart Association, and other organizations, as previously reported 16 (caloric intakes were individually determined according to the Harris-Benedict equation to achieve or maintain each subject at his/her estimated ideal body weight); or 2) a nutritionist-supervised (every 2 weeks) plan having the same dietary and weight goals as the CCNW plan but in which subjects prepared the food. Nutrition counseling was given during weeks 0 and 2 of the intervention period, and subjects on this self-selected diet (SSD) were remunerated for the cost of food purchased during the intervention period.
Blood pressure in the supine and sitting positions, weight, and 3-day food records for dietary compliance were assessed at 2-week intervals during the intervention period. Subjects collected 24-h urine specimens at weeks 0, 4, and 10 that were analyzed for sodium, potassium, calcium, magnesium, and creatinine content. Mineral excretion values were expressed either per milligram creatinine excretion or as a ratio relative to sodium excretion. Fasting blood samples were obtained at week 0 and at study end (week 10) for a general chemistry profile including blood glucose, total cholesterol, and triglycerides as well as hormonal levels of insulin, intact parathyroid hormone (PTH), 25(OH) vitamin D (25OHD), and 1,25 (OH) 2 D (1,25D). All blood and urine measurements used standard chemical and radioimmunoassay techniques.
Data Analysis
Basal, pre-and postintervention data, and their differences were compared by unpaired t tests for hypertensive versus normotensive subjects, and by one-way analysis of variance (ANOVA) with Bonferroni post hoc tests among hypertensive (HT), hypertensive hyperlipidemic (HTHL), and normotensive hyperlipidemic (NTHL) subjects. Basal data also were tested with a cross-tabs analysis and 2 statistics. Two-way ANOVA was performed to test the differential effect of CCNW versus SSD diets among the diagnostic groups. The relations of BP to other variables were analyzed by linear regression and Pearson correlation coefficients. Multiple regression analysis studied the interdependence of these relations among variables found to correlate significantly with BP. Data are expressed as the mean Ϯ SD.
RESULTS
Demographic and basal biochemical data are displayed in Table 1 for the 158 subjects (26 HT, 45 HTHL, and 87 NTHL) on no antihypertensive or antilipemic medications. Although age, racial composition, body mass index, and renal function indices did not differ significantly among the groups, there was a predominance of female subjects in the NTHL group. (Table 2 ) Blood pressure was higher among HT and HTHL compared with NTHL, but did not differ between HT and HTHL subjects. Both diets significantly lowered BP in all positions in all subjects.
Dietary Effects on Blood Pressure
For all subjects, a greater fall in systolic BP (SBP) (Ϫ6.2 Ϯ 1.0 v Ϫ4.2 Ϯ 0.8 mm Hg, P ϭ .033) and diastolic BP (DBP) (Ϫ4.2 Ϯ 0.7 v Ϫ2.3 Ϯ 0.4 mm Hg, P ϭ .002) was observed on CCNW versus the SSD diets (Fig. 1) . Among hypertensive subjects, this was limited to subjects with concomitant hyperlipidemia (SBP: supine Ϫ7 Ϯ 10 v Ϫ1 Ϯ 8 mm Hg; sitting Ϫ10 Ϯ 9 v Ϫ5 Ϯ 7 mm Hg, P Ͻ .05; DBP: Ϫ6 Ϯ 6 v Ϫ3 Ϯ 5 mm Hg, P Ͻ .05) ( Table 2 ). Similarly, although there was no difference in supine SBP or DBP changes induced by the CCNW diet in HT versus HTHL subjects (P ϭ .8, P ϭ .6, respectively), the SSD diet was consistently less effective in HTHL subjects (P ϭ .004, P ϭ .02, respectively). All ⌬ values are significantly different (P Ͻ .001) v basal.
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AJH-SEPTEMBER 2000 -VOL. 13, NO. 9 differ in HT versus HTHL subjects on either diet, thus not accounting for the enhanced depressor responses to CCNW versus SSD diets in HTHL subjects. Fasting blood glucose also declined on both diets in hypertensive but not in normotensive subjects. The decline in HbA1c values was insignificant, presumably because of the relatively short study duration. Total cholesterol levels fell (P Ͻ .05) in all subjects on both diets in all diagnostic groups, whereas the changes in triglyceride levels were not significant. For all subjects, fasting blood glucose (r ϭ 0.236, P ϭ .002) and HbA1c (r ϭ 0.251, P ϭ .001) were correlates of basal SBP, as was caloric intake (r ϭ 0.328, P Ͻ .0001) for basal DBP. For HT, basal fasting insulin levels (r ϭ 0.421, P ϭ .036) levels and, among NTHL, basal fasting glucose (r ϭ 0.265, P ϭ .014), cholesterol (r ϭ 0.330, P ϭ .002), and triglyceride (r ϭ 0.222, P ϭ .039) levels were predictors of SBP, as were basal insulin levels (r ϭ 0.261, P ϭ .018) for DBP among NTHL.
For all subjects, the response of SBP to either diet was significantly related to the concomitant changes in weight (r ϭ 0.444, P ϭ .00000002), cholesterol (r ϭ 0.2188, P ϭ .0064), and fasting blood glucose (r ϭ 0.2148, P ϭ .0088), but not to insulin (Fig. 2) . For cholesterol and glucose, these relationships were only significant among the HTHL and NTHL but not the normolipidemic HT subjects, despite an equivalent cholesterol-and glucose-lowering effect of the diets in the latter group.
With multivariate analysis, changes in fasting blood glucose (P ϭ .0134) and total cholesterol levels (P ϭ .0182) were independent predictors of diet-induced changes in SBP (R 2 ϭ 0.0822). However, their contributions were no longer statistically significant when the change in weight (P ϭ .000014) was added to the model (R 2 ϭ 0.2010), consistent with an interaction between changes in weight, cholesterol (r ϭ 0.546, P Ͻ .001), and glucose (r ϭ 0.184, P ϭ .029). (Table 4 ) Basal urinary sodium excretion was the same for each
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FIG. 2. Relation of diet-induced changes in body weight (left)
and serum cholesterol levels (right) to diet-induced changes in systolic (SBP) and diastolic (DBP) blood pressures. diagnostic group and did not change significantly on either diet. However, significant changes were observed in potassium, calcium, and magnesium excretion, with increases being greater on the CCNW plan. These changes presumably reflect the increased content of these minerals in the CCNW diet (P Ͻ .0001 for dietary calcium and magnesium for all groups, and P ϭ .0177 for potassium in HT) (Fig. 3) . Table 5 lists the changes in circulating hormones. Insulin levels fell significantly in the hypertensive groups. Basal PTH levels were elevated in HT versus the NTHL subjects and, in HT subjects, PTH and 1,25D levels fell significantly on the CCNW versus the SSD diet. No net changes in PTH or 1,25D were observed in the other diagnostic groups on either treatment. In both hyperlipidemic groups, 25OHD rose on the CCNW diet.
Diastolic BP, both basal (r ϭ Ϫ0.271, P Ͻ .001) and in response to diet (r ϭ 0.276, P ϭ .001) were significantly related to basal urinary potassium excretion (UKV), lower initial UKV values being associated with higher basal DBP and a greater depressor response. Furthermore, the greater the rise in UKV (SBP: r ϭ Ϫ0.307, P Ͻ .0001; DBP: r ϭ Ϫ0.295, P Ͻ .0001) and serum potassium (SBP: r ϭ Ϫ0.249, P ϭ .002; DBP: r ϭ Ϫ0.253, P ϭ .002), the more the BP fell.
Basal SBP also was directly related to urinary calcium excretion (UCaV) (P ϭ .018), particularly among HTHL (r ϭ 0.415, P ϭ .007) and NTHL (r ϭ 0.300, P ϭ .007) subjects. Additionally, when consid- Table 2 .
All values are adjusted for urinary creatinine excretion.
* P Ͻ .05 CCNW v Control (SSD) diet. AJH-SEPTEMBER 2000 -VOL. 13, NO. 9
.001/.021). Consistent with changes in PTH (see below), diet-induced changes in BP also were inversely related to changes in serum phosphorus (SBP: r ϭ Ϫ0.279, P ϭ .001; DBP: r ϭ Ϫ0.250, P ϭ .002) and to diet-induced alterations in magnesium excretion (SBP: r ϭ Ϫ0.254, P ϭ .003; DBP: r ϭ Ϫ219, P ϭ .01) (Fig.  4 ). Blood pressure in the basal state or in response to diet was not significantly related to the absolute level of, or to diet-induced changes in, urinary Na excretion. Relations between calcium regulating hormones and BP were consistent with the above, and appeared to reflect increased dietary mineral exposure. Thus, the greater the UCaV/UNaV, the greater the fall in PTH (r ϭ Ϫ0.252, P ϭ .003) and 1,25D (r ϭ Ϫ0.360, P ϭ .00002) (Fig. 5, right) . Our observations also confirm the known physiologic linkage of PTH and 1,25D levels (r ϭ 0.288, P ϭ .0006). Furthermore, not only was basal BP positively related to PTH (SBP: r ϭ 0.212, P ϭ .009; DBP: r ϭ 0.252, P ϭ .002), but higher basal PTH levels predicted a greater diet-induced SBP fall in pressure (P Ͻ .031). Finally, the more diet suppressed PTH and 1,25D, the more SBP fell (PTH: r ϭ 0.238, P ϭ .004; 1,25D: r ϭ 0.202, P ϭ .017) (Fig.  5, left) .
Multivariate regression indicated that the changes in pressure induced by either of the diets could not be accounted for solely on the basis of weight changes described above. Thus the SBP response, independently of the inclusion of weight in the model, was Table 2 .
FIG. 4. Relation of diet-induced changes in urinary magnesium excretion and diet-induced changes in systolic (SBP) and diastolic (DBP) blood pressures.
* P Ͻ .05 v pre-Rx. † P Ͻ .05 v NTHL. ‡ P Ͻ .05 CCNW v Control (SSD) diet.
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significantly related to diet-induced changes in urinary magnesium excretion, UMgV (P ϭ .030), urinary Ca/Na ratios (P ϭ .0389), PTH (P ϭ .0186), and 1,25 D (P ϭ .0246). In a final model including changes in urinary potassium, urinary Ca/Na ratio, PTH, and 1,25 D, as well as in glucose, cholesterol, and weight, only the change in UMgV remained significant: R 2 ϭ 0.3125, P(⌬UMgV) ϭ .0493.
DISCUSSION
Certain issues arising from previous nutritional interventions in hypertension form the basis of the present study. First, the physiological basis underlying effects of diet on BP remains uncertain, as most previous intervention trials have included little biochemical data. Second, with few exceptions, [15] [16] [17] these studies have tested the efficacy of altering single dietary components, with little assessment of the benefit of overall diets meeting current nutrient recommendations. Third, current diet policies have achieved only limited success, perhaps as a result of the lifestyle changes involved in their implementation. We have begun to address these issues by analyzing the BP, weight, biochemical, and hormonal responses to two food plans conforming to current guidelines of the American Heart Association and the National Academy of Sciences, and administered to unmedicated normotensive and hypertensive subjects with and without concomitant hyperlipidemia as part of a multicenter, randomized, controlled clinical trial. 16 The main findings of this study are that: 1) participants in all diagnostic groups on both diets exhibited lower BP over the course of the intervention; 2) BP fell to a greater extent in subjects on CCNW compared with SSD diets for the group as a whole, and among HTHL subjects in particular; 3) diet-induced weight loss was the most significant determinant of BP change, an effect partly mediated by decreases in fasting plasma glucose and cholesterol levels, and 4) independently of weight, the BP effects of diet are linked with diet-induced changes in mineral metabolism, perhaps mediated by vasoactive mineral regulating hormones. Thus, the greater the UKV, UMgV, and U(Ca/Na), the greater the suppression of PTH and 1,25D and, in turn, the greater the decline in BP (Fig.  4) .
This study adds both practical and scientific dimensions to previous reports of diet-based BP interventions. First, we have demonstrated that an already prepared meal plan can be at least as effective as traditional nutrition-counseled, self-selected diets in lowering BP (Fig. 1) . Second, although factors influencing depressor responses to diet have not been examined extensively, the role of weight loss has been emphasized. 13, 15 Our data support this conclusion, although the interaction on multivariate analysis of changes in weight, glucose, and cholesterol suggests that these biochemical consequences of weight loss may mediate this effect (Fig. 2) . The DASH trial 17 reported additive effects of two food classes, fruits and vegetables, and dairy products, and suggested a role for the calcium-conserving influence of potassium. 18 Although weight was kept stable in the DASH trial, in our study the contribution of mineral metabolism to basal and diet-induced changes in BP was apparent despite, and independently of, weight changes. Furthermore, the increase in K, Ca, and Mg in CCNW versus SSD subjects, and the dependence of BP on these minerals (see Results) may help to explain the differential efficacy of the CCNW versus SSD diet. Thus, our data are consistent with the DASH trial and may provide a physiologic basis for their results, suggesting that both trials reflect the additive contributions of K, Ca, and Mg. Furthermore, the BP effects observed here and in the DASH trial conform to projected estimates from previous cross-sectional studies of mineral intake and BP. 19 Our data also provide information regarding the hotly debated role of dietary salt in hypertension. They support the significance of Na, but in relation to other minerals such as calcium rather than as Na per se. Just as data from Montreal indicate an influence of salt intake on BP only in subjects with low calcium intake, 4 our study demonstrates the depressor effect of increased Ca in relation to concomitant levels of Na excretion (see Results and Fig. 5) . This is consistent with studies 10, 20, 21 in which the response to calcium was closely linked to the effect of salt-the more that salt elevated pressure, the more calcium lowered it. Thus, an altered Ca/Na ratio may be relevant, with lower ratios (deficient calcium or excess salt) predisposing to higher BP in "salt-sensitive" persons, reversible by restricting sodium or increasing calcium.
Mechanistically, the BP effects that are attributable to each of the factors identified above may have a common underlying basis, consistent with the ionic hypothesis of cardiovascular and metabolic disease. 22 First, 1) intracellular free calcium (Cai) and magnesium (Mgi) directly participate in vasoconstriction 23, 24 , 2) increased glucose and LDL each raise Cai and/or lower Mgi levels in vascular smooth muscle tissue, 25, 26 3) conditions responsive to weight reduction including hypertension, insulin resistance, and type 2 diabetes are characterized by elevations of Cai or depletion of Mgi, 27-29 and 4) weight loss lowers Cai. 12 Therefore, we suggest that weight loss and the associated decrease in glucose and cholesterol, by reversing the intracellular ionic abnormalities of hypertension, may help to explain the associated decreases in BP.
Second, that dietary minerals alter cellular ions may also explain their BP effects. This is so for several reasons: 1) dietary Ca-suppressible hormones such as PTH, 1,25 (OH) 2 D, and others 30 are vasoactive and promote cellular Ca uptake in heart 31 and vascular smooth muscle tissues 32 ; 2) the greatest depressor responses were in subjects with the highest basal PTH and the greatest diet-induced fall in PTH and 1,25 (OH) 2 D (Fig. 5); 3) elevated Cai, suppressed Mgi, and increased levels of the above Ca hormones exist in hypertension, especially in salt-and Ca-sensitive forms of hypertensive diseases. 33 Furthermore, dietary Ca lowers BP to the extent that it reverses these altered calcium indices 34 ; and 4) dietary K decreases UCaV and lowers circulating 1,25 (OH) 2 D levels, 11 whereas Mg loading decreases tissue Ca accumulation. 35 Altogether, we hypothesize that the BP effects of diet result from the additive contributions of multiple dietary components to intracellular ion levels. Indeed, each of the dietary components described here can alter Cai and Mgi levels. This may be accomplished directly by changes in circulating nutrient levels themselves, eg, glucose, and/or indirectly by changes in circulating regulators of nutrient metabolism, eg, LDL, PTH, and 1,25D, with each humoral mediator in turn altering cytosolic ion levels. 26, 31, 32 (Fig. 6 ) Certain limitations to the interpretation of our data must also be considered. First, because subject randomization was done without regard to medication status, the present data, which exclude subjects on medications known to influence the very metabolic factors being investigated, resulted in certain demographic inequalities among the groups, such as the imbalance in the male:female ratio between NTHL and HTHL subjects (Table 1) . Although little data are available on the subject, this may have influenced the different BP responses to the two diets. Second, differences in dietary compliance to the two diets, which was previously reported, 36 may also have contributed to different BP responses. Nevertheless, differences in urinary mineral excretion, which were determinants of the BP responses to either diet, closely paralleled differences in dietary content (Fig. 3) . Third, unlike the group as a whole, individual subgroups demonstrated no clear relation between changes in Ca regulating hormones and changes in UCaV. Multiple factors changing concomitantly make interpretation difficult, including the effects of UCaV of decreased dietary Na, increased dietary Ca (decreasing and increasing UCaV, respectively), and increased dietary Mg (especially on the CCNW diet).
In summary, these caveats notwithstanding, we believe that the data reported here have both pathophysiologic and practical implications. First, by demonstrating a link between changes in BP and changes in diet, we confirm the presumption derived from crosssectional and prospective epidemiologic surveys that multiple dietary components influence BP. Weight loss, mediated in part by concomitant changes in fasting glucose and cholesterol levels and, independently of weight, indices of mineral metabolism, each appear to contribute to diet-induced changes in BP. Second, the benefit of an overall diet plan versus altering only specific dietary components is suggested by results obtained in individuals with more than one clinical manifestation of "Syndrome X" (such as hyperlipidemia and hypertension), in whom an enhanced de- pressor response to the overall diet plan was observed. Finally, the availability of a nutritionally complete and prepared meal plan may promote improved compliance with dietary recommendations for hypertension. 36 Whether similarly beneficial results can be achieved with longer-term use of this meal plan is the focus of current research.
